Post on 05-Apr-2021
description
MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
FY2016 – FY2026
INDIA IN-VITRO DIAGNOSTICS MARKET
FORECAST & OPPORTUNITIES
2© TechSci Research
Scope of ReportProduct of Interest (POI): In-Vitro Diagnostics
Review Period
FY2016 – FY2019
Base Year
FY2020
Estimated Year
FY2021
Forecast Period
FY2021 – FY2026
Year Range
In vitro diagnostics are tests done on samples such as blood or tissuethat have been taken from the human body. In vitro diagnostics candetect diseases or other conditions, and can be used to monitor aperson's overall health to help cure, treat, or prevent diseases.
Market Segmentation
REGION
• North
• East
• West
• South
END USER
• Diagnostic
Laboratories
• Hospitals & Clinics
• Others
• Instrument
• Reagents
• Others
PRODUCT
TEST TYPE
• Clinical Chemistry
• Molecular Diagnostics
• Hematology
• Immuno Diagnostics
• Others
• Disposable IVD
Devices
• Reusable IVD
Devices
USABILITY
APPLICATION
• Infectious Disease
• Diabetes
• Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Others
3© TechSci Research
Table of Contents
S. No. Contents Page No
1. Product Overview (Definition of product and major terminologies used in the report)
2.Research Methodology (Detailed description of the methodology used to conduct the research,Raw data backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on India In-Vitro Diagnostics Market
4. Executive Summary
5. Voice of Customer
6. India In-Vitro Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Instrument, Reagent, Others)
6.2.2.By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, ImmunoDiagnostics, Others)
6.2.3. By Usability (Disposable IVD Devices, Reusable IVD Devices)
6.2.4.By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, Others)
6.2.5. By End User (Diagnostic Laboratories, Hospitals & Clinics, Others)
6.2.6. By Region (North, East, West, South)
6.2.7. By Company (FY2020)
6.3. Product Market Map
7. North India In-Vitro Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
4© TechSci Research
Table of Contents
S. No. Contents Page No.
7.2.2. By Test Type
7.2.3. By Usability
7.2.4. By Application
7.2.5. By End User
8. South India In-Vitro Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Test Type
8.2.3. By Usability
8.2.4. By Application
8.2.5. By End User
9. East India In-Vitro Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Test Type
9.2.3. By Usability
9.2.4. By Application
9.2.5. By End User
10. West India In-Vitro Diagnostics Market Outlook
5© TechSci Research
Table of Contents
S. No. Contents Page No.
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Test Type
10.2.3. By Usability
10.2.4. By Application
10.2.5. By End User
11. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
11.1. Drivers
11.2. Challenges
12.Market Trends and Developments (This section captures recent trends pertaining to manufacturingor consumption, market movements in terms of points of production and consumption,advancements and development)
13. Policy & Regulatory Landscape
14. India Economic Profile
15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles (Top 10 Leading Companies)
15.2.1. Company Details
15.2.2. Products & Services
15.2.3. Financials (As Reported)
15.2.4. Key Market Focus & Geographical Presence
15.2.5. Recent Developments
6© TechSci Research
Table of Contents
S. No. Contents Page No.
15.2.6. Key Management Personnel
16.Strategic Recommendations (Based on the findings of the report strategic recommendations on howto enter and expand market share)
17. About Us & Disclaimer
RESEARCH METHODOLOGY
8
Research Methodology
✓ Identifying Key Opinion
Leaders
✓ Questionnaire Design
✓ In-depth Interviews
Data Collection
Developing List of Respondents
Formulating Questionnaire
Market Profiling
Data Validation
Data Analysis
In-depth secondary research was conducted to
determine top players in India in-vitro diagnostics
market, overall market size and segmental market size.
In order to conduct industry experts’
interviews, TechSci formulated a detailed
discussion guide.
List of industry players and industry
specialists was developed.
TechSci conducted interviews with
industry experts and industry players for data collection and
verification.
Data obtained as a result of primary and secondary research was
validated through rigorous
triangulation.
The data was scrutinized using MS-Excel, statistical
tools and internal proprietary database to obtain qualitative and
quantitative insights about India in-vitro diagnostics
market.
Data
Collection
Data Filter
& AnalysisResearch &
Intelligence
Actionable
InsightsBusiness
Solution
Primary Research Desk Research Company Analysis
✓ Recent Developments
✓ Market Changing
Aspects/Dynamics
✓ Government Policies
✓ Conclusion
✓ Market Participants
✓ Key Strengths
✓ LinkedIn✓ TechSci Internal
Database
✓ Factiva✓ Hoovers
Paid Sources
✓ Company Websites✓ Company Annual
Reports✓ White Paper Study✓ Financial Reports✓ Investor
Presentations✓ Regulatory Body✓ Associations, etc.
Secondary Research
Primary Research
9
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of India in-vitro diagnostics market. The team has analyzed the
outlook of various segments of this market, while considering the major influencing factors such as rising patients of chronic and infectious diseases.
The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in
India in-vitro diagnostics market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year FY2020 was calculated based on information collected through exhaustive
secondary research and primary surveys, with various key opinion leaders/stakeholders, such as in-vitro diagnostics companies, channel partners,
end-user industry experts, and other industry participants.
• The team interviewed more than 15-20 in-vitro diagnostics companies, 100 – 120 end use industries, and 15 – 20 industry experts and other value
chain stakeholders in India In-Vitro Diagnostics market to obtain the overall market size for FY2016-FY2020, which was validated by the Delphi
technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data for FY2016-FY2020.
10
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by product, by test type, by usability, by application, by
end user, by region and by company. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares
generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were
further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares by product, by test type, by usability, by application, by end user, by region and by company were calculated based on the responses
received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from
various segments of India in-vitro diagnostics market. The final shares were calculated by taking the geometric mean of the responses gathered
from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in
SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India In-Vitro
Diagnostics market, TechSci Research used various forecast techniques such as:
✓ Moving Average
✓ Time Series Analysis
✓ Regression Analysis
✓ Econometric and Judgmental Analysis
11
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used
the impact analysis during short, medium and long- term period to estimate and analyse market demand scenario. It should be noted that the figures
compiled are only for the organized market including market share data.
Partial List of Companies Interviewed Key Secondary Sources
▪ Ortho Clinical Diagnostics India Private Limited
▪ Roche Diagnostics India Pvt. Ltd.
▪ Abbott India Limited
▪ Transasia Bio-Medicals Ltd.
▪ bioMérieux India Limited
▪ Becton Dickinson Private Limited
▪ Thermo Fisher Scientific India Pvt. Ltd.
▪ Siemens Healthineers India Pvt. Ltd.
▪ Sysmex India Pvt. Ltd.
▪ Angstrom Biotech Private Limited
▪ World Bank
▪ TechSci Research Proprietary Database & Knowledge
Repository
▪ Company Annual Reports
▪ Industry Magazines
▪ Industry Reports
▪ News Dailies
▪ Credible Paid Databases
© TechSci Research
12© TechSci Research
Industry Brief
According to TechSci Research report, “India In Vitro Diagnostics Market By Product (Instrument, Reagent, Other Products), By Test Type
(Clinical Chemistry, Molecular Diagnostics, Haematology, Immuno Diagnostics, Other Types), By Usability (Disposable In Vitro Diagnostics
Devices, Reusable In Vitro Diagnostics Devices), By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease,
Nephrology, Others), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), By Company, By Region, Forecast & Opportunities,
FY2026”, the India In Vitro Diagnostics market is expected to grow at a steady rate during the forecast period. Existence of several research
organizations providing consulting services, clinical research, and laboratory testing owing to high demand for rapid diagnosis and treatments is
projected to act as major market driving factor. Moreover, surging use of personalized medicines for treating a number of chronic diseases such
as cancer is further expected to fuel the market growth through FY2026. Furthermore, increased availability of over the counter tests is further
estimated to boost the growth of India In Vitro Diagnostics market. Increased government funding in healthcare sector for providing education
regarding In Vitro Diagnostics tools is further expected to drive the market growth during the forecast period. However, inadequate
reimbursement can restrict the market growth over the next few years. Moreover, stringent government regulations can further hinder the market
growth during the forecast period.
The India In Vitro Diagnostics market is segmented based on product, test type, usability, application, end user, company, and region. Based on
end user, the market can be fragmented into diagnostic laboratories, hospitals & clinics, others. The hospitals & clinics segment dominated the
market in terms of major market share and is expected to maintain its market position in the forthcoming years as well. This dominance is due to
growing need for immense amount of diagnostic testing in order to support a clinical decision for improving patient recovery. Based on
application, the market can be categorized into infectious disease, diabetes, oncology, cardiology, autoimmune disease, nephrology, others.
Among these, the infectious disease segment is expected to dominate the market over the forecast period which can be accredited to upsurge in
prevalence of infectious diseases in the country like pneumonia, tuberculosis, AIDS, and HIV.
Ortho Clinical Diagnostics India Private Limited, Danaher (DHR) Holding India Pvt Limited, Roche Diagnostics India Pvt. Ltd., Abbott India
Limited, Transasia Bio-Medicals Ltd., bioMérieux India Limited, Becton Dickinson Private Limited, Thermo Fisher Scientific India Pvt. Ltd.,
Siemens Healthineers India Pvt. Ltd., Sysmex India Pvt. Ltd and others are some of the leading players operating in India In Vitro Diagnostics
market. Companies operating in the market are using organic strategies such as product launches, mergers acquisitions and research
collaborations to boost their share and increase their geographic reach.
“India In Vitro Diagnostics market is expected to witness steady growth during the forecast period on account of rising demand for point-of-care
In Vitro Diagnostic devices. Along with this, increased adoption of In Vitro Diagnostic instruments/devices by healthcare professionals due to their
conveniency, is further forecast to bode well for the growth of In Vitro Diagnostics market in the country. Moreover, surging awareness about
disease diagnosis is further expected to create lucrative opportunities for growth for India In Vitro Diagnostics market over the next five years.”
said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
13© TechSci Research
Sample Data - Snapshot
India In-Vitro Diagnostics Market Size, By Value (USD Million), FY2016-FY2026F
5.00 6.00 7.008.00 9.00 10.00
11.00 12.00 13.0014.00 15.00
FY2016 FY2020 FY2021E FY2026F
By Value (USD Million)CAGR BY VALUE: XX% CAGR BY VALUE: XX%
India In-Vitro Diagnostics Market Share, By Test Type, By Value, 2015–2025F
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021E
FY2022F
FY2023F
FY2024F
FY2025F
FY2026F
Clinical Chemistry Molecular Diagnostics Hematology Immuno Diagnostics Others
North India In-Vitro Diagnostics Market Share, By Application, By Value, 2015–2025F
15%15%15%15%15%15%15%15%15%15%15%
15%15%15%15%15%15%15%15%15%15%15%
15%15%15%15%15%15%15%15%15%15%15%
15%15%15%15%15%15%15%15%15%15%15%
15%15%15%15%15%15%15%15%15%15%15%
15%15%15%15%15%15%15%15%15%15%15%
10%10%10%10%10%10%10%10%10%10%10%
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021E
FY2022F
FY2023F
FY2024F
FY2025F
FY2026F
Infectious Disease Diabetes Oncology Cardiology Autoimmune Disease Nephrology Others
14© TechSci Research
Report Ordering
License Type Price
Electronic Access - Single User License $2950
Electronic Access - Multi-User License $3750
Custom Research License $7500
Report Price
To View Sample OR Purchase Report
Report Name: INDIA IN-VITRO DIAGNOSTICS MARKET
FORECAST & OPPORTUNITIESFY2016 – FY2026
https://www.techsciresearch.com/report/india-in-vitro-diagnostics-market/7302.html
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting
models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and
global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the
market.
Related Reports
• India Therapeutic Drug Monitoring Market By Product (Consumables, Equipment), By Technology (In-Vitro Diagnosticss, Chromatography-Ms and
Others), By Class of Drug (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, and Others), By End User
(Hospital, Private Labs), By Region, Competition, Forecast & Opportunities, FY 2026
• India Streptomycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule and Injection), By Route of
Administration (Oral v/s Intravenous), By Type of Manufacturing Process (Natural, Synthetic and Semi-synthetic), By Distribution Channel (Online v/s
Offline), By Application (Tuberculosis, meningitis, throat Infection, endocarditis, brucellosis, plague, tularemia, rat bite fever and Others), By End User
(Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or
complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand.
However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results
obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together
with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal
consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
TechSci Research – North America708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com